Azimuth Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 19-06-2024
- Paid Up Capital ₹ 0.30 M
as on 19-06-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.43 Cr
as on 19-06-2024
- Revenue %
(FY 2017)
- Profit -53.39%
(FY 2017)
- Ebitda -53.39%
(FY 2017)
- Net Worth -33.75%
(FY 2017)
- Total Assets 3.24%
(FY 2017)
About Azimuth Drugs And Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.43 Cr.
Ahamed Puthukkidi, Hashim Cheriyandiyil, Kunhammad Nadukandiyil, and Fifteen other members serve as directors at the Company.
- CIN/LLPIN
U24233KL2010PTC025508
- Company No.
025508
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 2010
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Azimuth Drugs And Pharmaceuticals?
Board Members(18)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ahamed Puthukkidi  | Director | 16-Feb-2010 | Current |
| Hashim Cheriyandiyil | Director | 16-Feb-2010 | Current |
| Kunhammad Nadukandiyil | Director | 16-Feb-2010 | Current |
| Parambath Sajeesh | Additional Director | 15-Feb-2014 | Current |
| Abdul Kulath | Director | 16-Feb-2010 | Current |
| Shaji Muhammad | Additional Director | 15-Feb-2014 | Current |
Financial Performance of Azimuth Drugs And Pharmaceuticals.
Azimuth Drugs And Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 53.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azimuth Drugs And Pharmaceuticals?
In 2017, Azimuth Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asha Remedies Company Private LimitedActive 28 years 11 monthsMuhammad Saleena and Saseendran Thundiyil are mutual person
Al Madeena Institute Of Medical Science Private LimitedActive 27 years 5 monthsAhamed Puthukkidi is a mutual person
- Almas Ayurvedic Hospitals And Research Centre Private LimitedActive 10 years 11 months
Ahamed Puthukkidi is a mutual person
- Wipson Surgical Solutions LlpActive 3 years 6 months
Ahamed Puthukkidi, Hashim Cheriyandiyil and 5 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 May 2022 | ₹1.43 Cr | Open |
How Many Employees Work at Azimuth Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Azimuth Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azimuth Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azimuth Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
